Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process

Despite recent improvements in therapeutic management of osteosarcoma, ongoing challenges in improving the response to chemotherapy warrants new strategies still needed to improve overall patient survival. In this study, we investigated vivo the effects of RAD001 (Everolimus®), a new orally availabl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moriceau, Gatien, Ory, Benjamin, Mitrofan, Laura, Riganti, Chiara, Blanchard, Frédéric, Brion, Régis, Charrier, Céline, Battaglia, Séverine, Pilet, Paul, Denis, Marc, Shultz, Leonard D., Mönkkönen, Jukka, Rédini, Françoise, Heymann, Dominique
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3097388/
https://ncbi.nlm.nih.gov/pubmed/20971812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-0578
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados